Stonnington Group’s AbbVie ABBV Stock Holding History

Stonnington Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.7M	Sell	10,474 -999	-9%	-$153K	0.44%	59
2022 Q4	$1.83M	Sell	11,473 -486	-4%	-$74.5K	0.51%	53
2022 Q3	$1.71M	Sell	11,959 -899	-7%	-$129K	0.48%	59
2022 Q2	$1.95M	Buy	12,858 +451	+4%	+$68.9K	0.52%	56
2022 Q1	$2.11M	Sell	12,407 -215	-2%	-$31.2K	0.5%	54
2021 Q4	$1.73M	Sell	12,622 -2,391	-16%	-$282K	0.37%	74
2021 Q3	$1.67M	Sell	15,013 -513	-3%	-$58.6K	0.37%	74
2021 Q2	$1.81M	Buy	15,526 +3,200	+26%	+$360K	0.4%	68
2021 Q1	$1.42M	Buy	+12,326	New	+$1.32M	0.34%	82

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Stonnington Group's ABBV Position: Q1 2023 in Review

Stonnington Group reduced its AbbVie (ABBV) stake by 8.7% in Q1 2023, selling an estimated $153K and leaving 10,474 shares worth $1.7M. The position accounts for 0.44% of the portfolio, ranked #59.

Stonnington Group first reported a position in ABBV in Q1 2021 and has held it in 9 quarters since. The position peaked at $2.11M in Q1 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Stonnington Group held 10,474 shares of AbbVie worth $1.7M as of Q1 2023.
Stonnington Group sold 999 AbbVie shares in Q1 2023, an estimated $153K.
AbbVie made up 0.44% of Stonnington Group's portfolio in Q1 2023, its #59 holding.
Stonnington Group first reported a position in AbbVie in Q1 2021 and has held it in 9 quarters since.
Stonnington Group's AbbVie position peaked at $2.11M in Q1 2022.
3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.